NIVEGU.KNOW BEFORE YOU FLY

THE WORLD OF AVIATION.
YOUR JOURNEY, EXPLAINED.

Search Plan my trip
NASDAQ / LIVE COMPANY INTELLIGENCE

Arcadia Biosciences, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERRKDA
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / RKDA COVERAGE

What’s moving Arcadia Biosciences, Inc. now

Current reporting with the operating signal separated from the noise.

01
Arcadia Biosciences, Inc. Announces Q1 2025 Financial Results Release and Conference Call Schedule

Arcadia Biosciences, Inc. Announces Q1 2025 Financial Results Release and Conference Call Schedule

The story matters when it changes Arcadia Biosciences, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest RKDA filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-08-13 · Period 2026-06-30SEC ↗10-QQuarterly financial reportFiled 2026-05-14 · Period 2026-03-31SEC ↗10-K/AAnnual financial reportFiled 2026-04-30 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-09-15 · Period 2026-09-10SEC ↗8-KMaterial company eventFiled 2026-09-04 · Period 2026-08-31SEC ↗8-KMaterial company eventFiled 2026-08-13 · Period 2026-08-13SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-08-10 · Period 2026-08-10SEC ↗4Official SEC filingFiled 2026-09-14 · Period 2026-09-10SEC ↗
EARNINGS / QUARTERLY TRACKER

Arcadia Biosciences, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.